Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
Tseng Y.-L.
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 6 到 25 筆資料,總共 26 筆
< 上一頁
下一頁 >
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2012
Gallic acid attenuates platelet activation and platelet-leukocyte aggregation: Involving pathways of Akt and GSK3β
Chang S.-S.; Lee V.S.Y.; Tseng Y.-L.; Chang K.-C.; Chen K.-B.; YUH-LIEN CHEN
; Li C.-Y.
Evidence-based Complementary and Alternative Medicine
45
33
2019
High concentration of C5a-induced mitochondria-dependent apoptosis in murine kidney endothelial cells
I-JUNG TSAI
; WEI-CHOU LIN
; YAO-HSU YANG
; Tseng Y.-L.; YEN-HUNG LIN
; Chou C.-H.; Tsau Y.-K.
International Journal of Molecular Sciences
12
11
2011
High efficient driving circuit for traveling wave dielectrophoretic pump
Tseng Y.-L.; Huang C.-W.; U LEI
; Lin C.-W.
; FU-SHAN JAW
Measurement: Journal of the International Measurement Confederation
5
5
2008
Human Leukocyte Antigen-DR Matching Improved Skin Graft Survival From Transgenic Pigs to Accommodate SCID Mice Reconstituted With Human Peripheral Blood Mononuclear Cells
Tu C.-F.; HAO-CHIH TAI
; Chen C.-M.; Huang T.-T.; JANG-MING LEE
; Yang T.-S.; Chen C.-H.; Tseng Y.-L.; NAI-KUAN CHOU
; PO-HUANG LEE
Transplantation Proceedings
2
1
2011
Improvements in endotoxemic syndromes using a disintegrin, rhodostomin, through integrin alphav beta 3-dependent pathway
Hsu C.-C.; Chuang W.-J.; Chang C.-H.; Tseng Y.-L.; Peng H.-C.; TUR-FU HUANG
Journal of Thrombosis and Haemostasis
19
19
2010
The in vitro protection of human decay accelerating factor and hDAF/heme oxygenase-1 transgenes in porcine aortic endothelial cells against sera of formosan macaques
Tu C.-F.; HAO-CHIH TAI
; Wu C.-P.; Ho L.-L.; Lin Y.-J.; Hwang C.-S.; Yang T.-S.; JANG-MING LEE
; Tseng Y.-L.; Huang C.-C.; Weng C.-N.; PO-HUANG LEE
Transplantation Proceedings
6
5
2017
Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study
MING-WHEI YU
; Lin C.-L.; CHUN-JEN LIU
; Yang S.-H.; Tseng Y.-L.; Wu C.-F.
Gastroenterology
129
117
2004
Inhibitory effects of human alpha2-macroglobulin and mouse serum on the PSGL-1 and glycoprotein Ib proteolysis by a snake venom metalloproteinase, triflamp
Tseng Y.-L.; Wu W.-B.; Hsu C.-C.; Peng H.-C.; TUR-FU HUANG
Toxicon
10
9
2008
Long-Term Survival of HLA-DR15+ Pig Skin in SCID Mice After Reconstitution With Human Peripheral Blood Mononuclear Cells and Under Short-Term Immunosuppression
HAO-CHIH TAI
; Tu C.-F.; JANG-MING LEE
; Ho L.-L.; Tseng Y.-L.; NAI-KUAN CHOU
; Yang T.-S.; Weng C.-N.; PO-HUANG LEE
; KING-JEN CHANG
; Tang Y.-B.
Transplantation Proceedings
1
1
2004
A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery
Lee T.-Y.; Wu H.-C.; Tseng Y.-L.; CHIN-TARNG LIN
Cancer Research
77
72
2000
Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study
RUEY-LONG HONG
; Tseng Y.-L.; FU-HSIUNG CHANG
Annals of Oncology
22
19
2001
Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: The relation between pharmacokinetic property and toxicity
RUEY-LONG HONG
; Tseng Y.-L.
Cancer
81
2012
A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor
SHIH-HUNG YANG
; CHIA-CHI LIN
; ZHONG-ZHE LIN
; Tseng Y.-L.; RUEY-LONG HONG
Investigational New Drugs
34
28
2003
A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma
RUEY-LONG HONG
; Tseng Y.-L.
Cancer Chemotherapy and Pharmacology
41
38
2004
Rhodostomin, a disintegrin, inhibits adhesion of neutrophils to fibrinogen and attenuates superoxide production
Tseng Y.-L.; Peng H.-C.; TUR-FU HUANG
Journal of Biomedical Science
21
23
2010
A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation
Tseng Y.-L.; Chiang M.-L.; TUR-FU HUANG
; Su K.-P.; Lane H.-Y.; Lai Y.-C.
Thrombosis Research
56
52
2002
Simple and efficient liposomal encapsulation of topotecan by ammonium sulfate gradient: Stability, pharmacokinetic and therapeutic evaluation
Liu J.-J.; RUEY-LONG HONG
; WEN-FANG CHENG
; Hong K.; FU-HSIUNG CHANG
; Tseng Y.-L.
Anti-Cancer Drugs
38
35
1999
Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model
Tseng Y.-L.; RUEY-LONG HONG
; Tao M.-H.; FU-HSIUNG CHANG
International Journal of Cancer
62
2002
Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and Tat: A kinetic and efficacy study
Tseng Y.-L.; Liu J.-J.; RUEY-LONG HONG
Molecular Pharmacology
218
205
2013
Triflamp (Trimeresurus flavoviridis)
Tseng Y.-L.; TUR-FU HUANG
Handbook of Proteolytic Enzymes
0
0